Acer Therapeutics Inc Stock Price. Everything You Need To Know About The Acer Therapeutics Inc Stock! Acer Therapeutics Inc Stock Price. Everything You Need To Know About The Acer Therapeutics Inc Stock!


Acer Therapeutics, Inc. is a pharmaceutical company headquartered in Newton, Massachusetts, and employs 33 full-time employees. The company went IPO on September 1, 2006. Acer Therapeutics’ pipeline includes four programs: ACER-001 (sodium phenylbutyrate), ACER-801 (osanetant), EDSIVO (celiprolol), and ACER-2820 (emetine).

ACER-001 (sodium phenylbutyrate) is being developed for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD). ACER-801 (osanetant) is being developed for the treatment of induced vasomotor symptoms (iVMS), while EDSIVO (celiprolol) is being developed for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation. Lastly, ACER-2820 (emetine) is a host-directed therapy being developed against a variety of viruses, including cytomegalovirus, zika, dengue, ebola, and COVID-19.

Investors and industry professionals can stay up-to-date with Acer Therapeutics, Inc. by keeping an eye on its stock price and shares. As a pharmaceutical company focused on developing treatments for various diseases, it’s important to monitor the progress of its pipeline programs and the success of its clinical trials to understand the potential impact on the industry and patients.



Acer Therapeutics Inc Stock Price. Everything You Need To Know About The Acer Therapeutics Inc Stock! performance

  • Employees 33
  • Company HQ Newton
  • Website https://acertx.com/
  • Asset Type
  • Market Capitalization 0
  • Earnings Per Share
  • Dividends Per Share
  • Dividend Date
  • Quarterly Earnings Growth

Are you interested in investing in the healthcare sector? Look no further than Acer Therapeutics. As a leading pharmaceutical company, Acer Therapeutics focuses on developing innovative treatments for serious rare and life-threatening diseases. With a proven track record of success, this stock presents an exciting opportunity for investors from Malaysia, Thailand, Indonesia, and Vietnam. But how can you invest in Acer Therapeutics? Our platform, Zorion, provides you with the tools you need to stay informed and make educated investment decisions. With our investment insights and recommendations, along with access to educational resources, you can confidently invest in Acer Therapeutics and diversify your portfolio. Start your investment journey today!


Want To Buy Acer Therapeutics Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: